Prehabilitation of swallowing difficulties in people with head and neck cancer: A pilot cluster randomised trial and process evaluation

niversity College London0 sites72 target enrollmentMarch 4, 2022

Overview

No summary available.

Registry

who.int

Start Date

March 4, 2022

End Date

July 30, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity College London

•1\. Adults over the age of 18 years.
•2\. Both males and females.
•3\. Clinical and Radiological diagnosis of new stage III/IV tumour of the head and neck (oral cavity, oropharynx, nasopharynx, hypopharynx, mandible, maxilla, unknown primary with planned bilateral neck radiation)
•4\. Discussed at the multidisciplinary team (MDT) meeting and planned for treatment with curative intent via surgery, radiotherapy, chemoradiotherapy or combinations thereof.
•5\. Able to provide informed consent.
•6\. Patients who do not have English as their first language but for whom appropriate translation services as per local hospital practice is in place.

•1\. Patients with a previous diagnosis of head and neck cancer.
•2\. Patients who have not consented prior to cancer treatment, or those receiving palliation.
•3\. Patients who are to be treated solely by non\-standard treatment such as photodynamic therapy, brachytherapy or chemotherapy alone.
•4\. Patients who are planned for a total laryngectomy or long\-term tracheostomy.
•5\. Patients who are vulnerable and/or have significant co\-morbidities as determined by the clinical team and/or with a score of 4 on the WHO performance status scale.
•6\. Patients who have long\-term medical history of neurological conditions resulting in known pre\-existing dysphagia.
•7\. Patients with brain tumours and other primary sites not within head and neck.
•8\. Patients who are unable to provide informed consent